NOVARTIS AG Patent Application Trends in 2025
NOVARTIS AG Patent Filing Activity
NOVARTIS AG patent applications in 2025
Error creating thumbnail: File missing
Top 10 Technology Areas
- C07K2317/92 (PEPTIDES (peptides in foodstuffs)
- Count: 9 patents
- Example: 20250034240. IL-18 BINDING MOLECULES (NOVARTIS AG)
- A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca)
- Count: 8 patents
- Example: 20250032488. METHODS OF TREATMENT USING LOU064 (NOVARTIS AG)
- C07K2317/76 (PEPTIDES (peptides in foodstuffs)
- Count: 7 patents
- Example: 20250034240. IL-18 BINDING MOLECULES (NOVARTIS AG)
- C07K2317/565 (PEPTIDES (peptides in foodstuffs)
- Count: 7 patents
- Example: 20250034241. SELECTIVE REDUCTION OF CYSTEINE RESIDUES IN IL-17 ANTIBODIES (NOVARTIS AG)
- A61P35/00 (Antineoplastic agents)
- Count: 6 patents
- Example: 20250034259. Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof (Novartis AG)
- C07K2317/21 (PEPTIDES (peptides in foodstuffs)
- Count: 5 patents
- Example: 20250034241. SELECTIVE REDUCTION OF CYSTEINE RESIDUES IN IL-17 ANTIBODIES (NOVARTIS AG)
- A61K2039/505 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 5 patents
- Example: 20250034259. Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof (Novartis AG)
- A61K9/0019 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations)
- Count: 5 patents
- Example: 20250034280. METHOD AND APPARATUS FOR USING OMALIZUMAB (Novartis AG)
- C07K2317/24 (PEPTIDES (peptides in foodstuffs)
- Count: 4 patents
- Example: 20250034241. SELECTIVE REDUCTION OF CYSTEINE RESIDUES IN IL-17 ANTIBODIES (NOVARTIS AG)
- A61K39/3955 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 4 patents
- Example: 20250034259. Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof (Novartis AG)
Emerging Technology Areas
- G01N33/5044 ({involving specific cell types})
- Count: 1 patents
- Example: 20250012781. METHODS FOR DETERMINING THE BIOLOGICAL ACTIVITY OF ANGPTL POLYPEPTIDES (Novartis AG)
- G01N33/5023 ({on expression patterns})
- Count: 1 patents
- Example: 20250012781. METHODS FOR DETERMINING THE BIOLOGICAL ACTIVITY OF ANGPTL POLYPEPTIDES (Novartis AG)
- C12N2740/15041 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250011461. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- C07K2319/74 (PEPTIDES (peptides in foodstuffs)
- Count: 1 patents
- Example: 20250011461. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- C07K2319/00 (PEPTIDES (peptides in foodstuffs)
- Count: 1 patents
- Example: 20250011461. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- A61K2039/5158 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20250011461. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- A61K38/00 (Medicinal preparations containing peptides (peptides containing beta-lactam rings)
- Count: 1 patents
- Example: 20250011461. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- C12N15/85 (for animal cells)
- Count: 1 patents
- Example: 20250011461. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- C12N5/0638 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- Count: 1 patents
- Example: 20250011461. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- C07K16/3069 (PEPTIDES (peptides in foodstuffs)
- Count: 1 patents
- Example: 20250011461. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
Top Inventors
- Philippe Michel Rene BOUILLOT (3 patents)
- Emeric REYNAUD (3 patents)
- Jay Francis LARROW of Wakefield MA (US) (2 patents)
- Tajesh PATEL of Westford MA (US) (2 patents)
- Maria Chaikou (2 patents)
- Mathieu Paul- LĂŠon Rigollet (2 patents)
- Simone BONAZZI of Cambridge MA (US) (2 patents)
- Jennifer Stroka COBB of Stow MA (US) (2 patents)
- Matthew James HESSE of Pittsburgh PA (US) (2 patents)
- John Ryan KERRIGAN of Wakefield MA (US) (2 patents)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
Categories:
- NOVARTIS AG
- Companies
- CPC A61K31/505
- CPC A61K45/06
- CPC A61P37/08
- CPC C07D401/04
- CPC A61K31/41
- CPC A61K31/4439
- CPC C07D257/04
- CPC C07D401/12
- CPC C07D491/048
- CPC C07D487/04
- CPC A61P25/28
- CPC C07D487/14
- CPC C07D498/14
- CPC C07K16/244
- CPC G01N33/6854
- CPC C07K2317/34
- CPC C07K2317/76
- CPC C07K2317/92
- CPC C12P21/005
- CPC G01N2333/54
- CPC C07K2317/14
- CPC C07K2317/21
- CPC C07K2317/24
- CPC C07K2317/40
- CPC C07K2317/565
- CPC C07K16/2827
- CPC A61K38/1774
- CPC A61K39/3955
- CPC A61P35/00
- CPC C07K16/2896
- CPC C07K16/30
- CPC A61K2039/505
- CPC C07K2317/51
- CPC C07K2317/515
- CPC C07K2317/56
- CPC C07K16/2878
- CPC C07K2317/41
- CPC C07K2317/52
- CPC C07K2317/55
- CPC C07K2317/72
- CPC C07K2317/732
- CPC C07K16/4291
- CPC A61K9/0019
- CPC A61K47/183
- CPC A61K47/22
- CPC A61K47/26
- CPC A61M5/31513
- CPC A61M5/3243
- CPC A61K47/6849
- CPC A61K38/07
- CPC A61K38/12
- CPC A61K47/68031
- CPC A61K47/68033
- CPC A61K47/6831
- CPC C07K16/2803
- CPC C07K16/22
- CPC C07K1/00
- CPC C07K7/06
- CPC C07K2317/54
- CPC C07K2317/567
- CPC C07K2317/622
- CPC C07K2317/73
- CPC A61P19/02
- CPC A61K2039/545
- CPC C07K2317/32
- CPC C07K2317/94
- CPC C07K16/2818
- CPC G01N33/566
- CPC G01N33/57484
- CPC C07K2317/31
- CPC C07K2317/569
- CPC C07K2317/74
- CPC G01N2333/70596
- CPC Y02A50/30
- CPC C12N15/86
- CPC C07K14/47
- CPC C12N15/1137
- CPC C12N15/64
- CPC C12Y115/01001
- CPC A61K39/4611
- CPC A61K39/4631
- CPC A61K39/464402
- CPC A61K39/464412
- CPC C07K14/7051
- CPC C07K14/70517
- CPC C07K14/70578
- CPC C07K16/2809
- CPC C12N5/0636
- CPC C07K2317/53
- CPC C07K2319/02
- CPC C07K2319/03
- CPC C12N2501/2302
- CPC C12N2501/2306
- CPC C12N2501/2307
- CPC C12N2501/2315
- CPC A61K48/0066
- CPC A61K48/0033
- CPC C12N2750/14143
- CPC C12N2750/14145
- CPC C12N2750/14152
- CPC C12N2750/14162
- CPC C07D403/14
- CPC A61P7/00
- CPC C07D405/14
- CPC C07D417/14
- CPC C07D221/04
- CPC C07B2200/13
- CPC A61K31/397
- CPC A61K9/2013
- CPC A61K9/2018
- CPC A61K9/2027
- CPC A61K9/2054
- CPC A61K31/506
- CPC A61K31/553
- CPC A61K31/635
- CPC A61K31/704
- CPC A61K31/7068
- CPC A61K31/58
- CPC A61K31/4155
- CPC A61K31/4375
- CPC A61K9/1617
- CPC A61K9/2004
- CPC A61K9/2081
- CPC A61K9/209
- CPC A61K9/2806
- CPC A61K9/2886
- CPC A61K9/5026
- CPC A61K9/5089
- CPC C07D471/04
- CPC A61K31/519
- CPC A61K31/5377
- CPC A61K31/343
- CPC A61P31/14
- CPC C07D307/93
- CPC A61K9/2077
- CPC A61K9/284
- CPC A61K31/496
- CPC A61K51/088
- CPC C07B59/008
- CPC A61K2121/00
- CPC A61K2123/00
- CPC C07B2200/05
- CPC C07D401/14
- CPC A61K31/4725
- CPC A61K31/501
- CPC A61K31/454
- CPC A61K31/4545
- CPC C07D401/06
- CPC C07D491/052
- CPC C07D471/10
- CPC C07D519/00
- CPC A61K9/0053
- CPC A61P7/06
- CPC A61K31/55
- CPC A61P17/00
- CPC C12N15/113
- CPC A61K47/542
- CPC C12N2310/11
- CPC C12N2310/14
- CPC C12N2310/3233
- CPC C12N2310/351
- CPC A61K31/426
- CPC A61K9/10
- CPC A61K9/14
- CPC A61K9/1647
- CPC A61K9/50
- CPC A61K9/5015
- CPC A61K38/08
- CPC A61K38/31
- CPC A61K47/32
- CPC A61K47/34
- CPC C07D205/04
- CPC G16H50/20
- CPC G16H10/40
- CPC G16H10/60
- CPC G16H50/70
- CPC A61K31/444
- CPC C07K16/084
- CPC A61K9/19
- CPC A61K39/42
- CPC C07K2317/20
- CPC C07K2317/33
- CPC A61K31/282
- CPC A61K31/7048
- CPC A61K51/083
- CPC C07D405/04
- CPC A61K31/4025
- CPC C07D307/81
- CPC A61K31/5025
- CPC A61K31/53
- CPC A61K31/5365
- CPC A61K31/5383
- CPC A61K31/551
- CPC A61P31/16
- CPC C07D471/14
- CPC C07K2317/524
- CPC C07K2317/71
- CPC A61K31/436
- CPC A61K38/1793
- CPC A61K39/001168
- CPC A61K39/39558
- CPC A61K39/464468
- CPC A61K48/0058
- CPC A61K2239/31
- CPC A61K2239/38
- CPC A61K2239/48
- CPC A61K2239/54
- CPC A61K2239/59
- CPC C07K14/7151
- CPC C07K16/303
- CPC C07K16/3061
- CPC C07K16/3069
- CPC C12N5/0638
- CPC C12N15/85
- CPC A61K38/00
- CPC A61K2039/5158
- CPC C07K2319/00
- CPC C07K2319/74
- CPC C12N2740/15041
- CPC G01N33/5023
- CPC G01N33/5044
- Patent Trends by Company in 2025